ChapmanHD, JeffersTK, WilliamsRB. Forty years of monensin for the control of coccidiosis in poultry. Poult Sci, 2010; 89(9):1788–1801; doi: 10.3382/ps.2010-00931
2.
ŁowickiD, HuczyńskiA. Structure and antimicrobial properties of monensin A and its derivatives: Summary of the achievements. Biomed Res Int, 2013; 2013:e742149; doi: 10.1155/2013/742149
3.
MarkowskaA, KaysiewiczJ, MarkowskaJ, et al.Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs. Bioorg Med Chem Lett, 2019; 29(13):1549–1554; doi: 10.1016/j.bmcl.2019.04.045
4.
DecortiG, Bartoli KlugmannF, CrivellatoE, et al.Effect of the carboxylic ionophore monensin on histamine release from rat peritoneal mast cells. Agents Actions, 1991; 32(3–4):253–260; doi: 10.1007/BF01980882
5.
MaccaranaM, LiuJ, LampinenM, et al.Monensin induces selective mast cell apoptosis through a secretory granule-mediated pathway. Allergy, 2022; 77(3):1025–1028; doi: 10.1111/all.15157
DasRK, HerrKB, ParkarA, et al.Increased tongue use enhances 5-HT2C receptor immunostaining in hypoglossal motor nucleus. Respir Physiol Neurobiol, 2019; 260:105–113; doi: 10.1016/j.resp.2018.11.005
8.
HerkenrathSD, RanderathWJ. More than heart failure: Central sleep apnea and sleep-related hypoventilation. Respiration, 2019; 98(2):95–110; doi: 10.1159/000500728
9.
RaurichJ-M, RialpG, IbáñezJ, et al.Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO2 response and acetazolamide treatment effects. Respir Care, 2010; 55(11):1442–1448
10.
McBrienNA, CottriallCL, AnniesR. Retinal acetylcholine content in normal and myopic eyes: A role in ocular growth control?. Vis Neurosci, 2001; 18(4):571–580; doi: 10.1017/S0952523801184075
11.
CarrBJ, MiharaK, RamachandranR, et al.Myopia-inhibiting concentrations of muscarinic receptor antagonists block activation of alpha2A-adrenoceptors in vitro. Invest Ophthalmol Vis Sci, 2018; 59(7):2778–2791; doi: 10.1167/iovs.17-22562
12.
MathisU, FeldkaemperM, WangM, et al.Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken. Graefes Arch Clin Exp Ophthalmol, 2020; 258(2):319–333; doi: 10.1007/s00417-019-04573-y
13.
ThomsonK, KellyT, KaroutaC, et al.Insights into the mechanism by which atropine inhibits myopia: Evidence against cholinergic hyperactivity and modulation of dopamine release. Br J Pharmacol, 2021; 178(22):4501–4517; doi: 10.1111/bph.15629
14.
BachyE, CamusV, ThieblemontC, et al.Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). J Clin Oncol, 2022; 40(3):242–251; doi: 10.1200/JCO.21.01815
15.
FalchiL, MaH, KleinS, et al.Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: A multicenter phase 2 study. Blood, 2021; 137(16):2161–2170; doi: 10.1182/blood.2020009004
16.
SøgaardOS, GraversenME, LethS, et al.The depsipeptide romidepsin reverses HIV-1 latency in vivo. PLOS Pathog, 2015; 11(9):e1005142; doi: 10.1371/journal.ppat.1005142
17.
QinL, MaK, WangZ-J, et al.Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition. Nat Neurosci, 2018; 21(4):564–575; doi: 10.1038/s41593-018-0110-8
18.
HirokawaY, HanemannCO, KurtzA, et al.Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biol Ther, 2005; 4(4):385–387; doi: 10.4161/cbt.4.4.1649
19.
WangY, LuY-F, LiC-L, et al.Involvement of Rac1 signalling pathway in the development and maintenance of acute inflammatory pain induced by bee venom injection. Br J Pharmacol, 2016; 173(5):937–950; doi: 10.1111/bph.13413
20.
PatwaS, BensonCA, DyerL, et al.Spinal cord motor neuron plasticity accompanies second-degree burn injury and chronic pain. Physiol Rep, 2019; 7(23):e14288; doi: 10.1481/4/phy2.14288
21.
SenapatiS, BanerjeeP, BhagavatulaS, et al.Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19. J Genet, 2021; 100(1):12; doi: 10.1007/s12041-021-01262-w
22.
RensiS, KeysA, LoY-C, et al.Homology modeling of TMPRSS2 yields candidate drugs that may inhibit entry of SARS-CoV-2 into human cells. ChemRvix, 2020. [Epub ahead of print]; doi: 10.2643/4/chemrxiv.12009582
23.
PoojaM, ReddyGJ, HemaK, et al.Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies. Eur J Pharmacol, 2021; 890:173688; doi: 10.1016/j.ejphar.2020.173688
24.
HempelT, ElezK, KrügerN, et al.Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties. Chem Sci, 2021; 12(38):12600–12609; doi: 10.1039/D1SC01494C
25.
VlachosN, LamprosM, VoulgarisS, et al.Repurposing antipsychotics for cancer treatment. Biomedicines, 2021; 9(12):1785; doi: 10.3390/biomedicines9121785
26.
KasiAS, LiH, HarfordK-L, et al.Congenital central hypoventilation syndrome: Optimizing care with a multidisciplinary approach. J Multidiscip Healthc, 2022; 15:455–469; doi: 10.2147/JMDH.S284782
27.
HuntCE, InwoodRJ, ShannonDC. Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. Am Rev Respir Dis, 1979; 119(2):263–269; doi: 10.1164/arrd.1979.119.2.263
28.
BachettiT, BoccaP, BorghiniS, et al.Geldanamycin promotes nuclear localisation and clearance of PHOX2B misfolded proteins containing polyalanine expansions. Int J Biochem Cell Biol, 2007; 39(2):327–339; doi: 10.1016/j.biocel.2006.08.014
29.
CaoY-J, DreixlerJC, RoizenJD, et al.Modulation of recombinant small-conductance Ca2+-activated K+ channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther, 2001; 296(3):683–689
30.
BaiY, MaX. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo. Int Immunopharmacol, 2020; 88:106790; doi: 10.1016/j.intimp.2020.106790
31.
WuR-L, AnthesJC, KreutnerW, et al.Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-κB activity consistent with inverse agonism at the histamine H1 receptor. Int Arch Allergy Immunol, 2004; 135(4):313–318; doi: 10.1159/000082325
32.
NakamuraT, HiraokaK, HaradaR, et al.Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine. Pharmacol Res Perspect, 2019; 7(4):e00499; doi: 10.1002/prp2.499
33.
BoerJ, EderveenE, GrundmarkB. Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects. Ups J Med Sci, 2018; 123(3):174–178; doi: 10.1080/03009734.2018.1489918
34.
García-GrimshawM, SankowskiR, Valdés-FerrerSI. Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: Pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Neurol, 2022; 35(3):375; doi: 10.1097/WCO.0000000000001046
35.
KäuferC, SchreiberCS, HartkeA-S, et al.Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine, 2022; 79:103999; doi: 10.1016/j.ebiom.2022.103999
36.
ReichN, HölscherC. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review. Front Neurosci, 2022; 16:970925; doi: 10.3389/fnins.2022.970925
37.
SterlingJK, AdetunjiMO, GutthaS, et al.GLP-1 receptor agonist NLY01 reduces retinal inflammation and neuron death secondary to ocular hypertension. Cell Rep, 2020; 33(5):108271; doi: 10.1016/j.celrep.2020.108271
38.
OdiR, InvernizziRW, GallilyT, et al.Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know. Pharmacol Ther, 2021; 226:107866; doi: 10.1016/j.pharmthera.2021.107866
39.
SamantaD. Fenfluramine: A review of pharmacology, clinical efficacy, and safety in epilepsy. Children, 2022; 9(8):1159; doi: 10.3390/children9081159
40.
ZebischM, JonesEY. ZNRF3/RNF43—A direct linkage of extracellular recognition and E3 ligase activity to modulate cell surface signalling. Prog Biophys Mol Biol, 2015; 118(3):112–118; doi: 10.1016/j.pbiomolbio.2015.04.006
41.
ReesPA, CloustonHW, DuffS, et al.Colorectal cancer and thrombosis. Int J Colorectal Dis, 2018; 33(1):105–108; doi: 10.1007/s00384-017-2909-2
42.
LiS, WangL, SunS, et al.Hepsin: A multifunctional transmembrane serine protease in pathobiology. FEBS J, 2021; 288(18):5252–5264; doi: 10.1111/febs.15663
43.
Garcia-SchürmannJM, SchulzeH, HauptG, et al.Suramin treatment in hormone- and chemotherapy-refractory prostate cancer. Urology, 1999; 53(3):535–541; doi: 10.1016/S0090-4295(98)00544-5
44.
KornhuberJ, TripalP, ReichelM, et al.Identification of new functional inhibitors of acid sphingomyelinase using a structure−property−activity relation model. J Med Chem, 2008; 51(2):219–237; doi: 10.1021/jm070524a
45.
BeckmannN, SharmaD, GulbinsE, et al.Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons. Front Physiol, 2014; 5:331; doi: 10.3389/fphys.2014.00331
46.
SharmaD, CzarnotaGJ. Role of acid sphingomyelinase-induced ceramide generation in response to radiation. Oncotarget, 2019; 10(1):6–7; doi: 10.1863/2/oncotarget.26526
